Reddit Posts
Emerging Biosolutions $EBS at $2, 20pct of Book Value; Ramping Up FDA approved NARCAN nasal spray
$EBS Buy this $2 BioTech supplier just ramping up sales of Narcan (Anti Opioid FDA approved Nasal Spray)
Narcan from $EBS approved by FDA as an OTC med; on Walgreen/CVS shelves in Sepgtember
FDA Approves NARCAN at $EBS; On Walgreen and CVS Shelves in September
Narcan was approved for over the counter. Will we see a squeeze for EBS?
FDA approves over the counter NARCAN.
Emergent Biosolutions (EBS): Last and Final Boarding Call
EBS has potential for a run this coming week
$EBS to be approved BY March 29th for NARCAN to be sold over the counter.
$EBS to be approved BY March 29th for NARCAN to be sold over the counter.
EBS , BHC , EBS are possible high day runners.
EBS update since my post 11d ago, and FDA ruling still pends on OTC Narcan.
$EBS Emergent BioSolutions stock
We got any thoughts on Emergent Biosolutions (EBS)?
CMRX has a strong chance at a significant jump due to the shortage of vaccines and the spread of Monkeypox. They make the pill. Short interest is high and just bounced off of an upward 30 day moving average. CMRX gets an extra 100 million for Tembexa from EBS if Biden obliges.
Monkey pox movers on possible US Public Health Emergency Declaration
Monkey pox movers on possible US Public Health Emergency Declaration news
$EBS and Monkey Pox- an update on earlier comments of few weeks ago
Emergent BioSolutions ($EBS): Biden's Coronavirus and Harris's major lobbyist.
From July 5th to today July 8th a total of 9014 cases of monkeypox has been identified globally $SIGA $CMRX $EBS $LH $ABT In my opinion cases will hit next week more than 15k+ internationally
From July 5th to today July 8th a total of 9014 cases of monkeypox has been identified globally $SIGA $CMRX $EBS $LH $ABT In my opinion cases will hit next week more than 15k+ internationally
$EBS Govt approved Vaccine supplier for SmallPox and MonkeyPox
Monkeypox is mutating fast $SIGA $CMRX $EBS
WHO will declare Monkeypox a PHEIC by Sunday $BAVA FINAL DD
WHO will make Monkeypox a PHEIC by Sunday $BAVA $BVNRY
MonkeyPox Outbreak - $EBS - Opportunity!
Monkeypox: a money making opportunity from the strangest timeline
Let's make monkeypox into a moneybox. $EBS, $SIGA
Let's make monkeypox to moneybox. $EBS, $SIGA
is monkeypox gonna monkeynut all over the world? if so: DD time
Monkey pox EBS gains 1k to 13k sold in a few days
EU Health Agency Advises Member States to Plan for Monkeypox Jabs
Original Monkeypox DD - Part 2 - Update and Outlook $EBS $BAVA
Original Monkeypox DD - Part 2 $EBS $BVNRY - Update and Outlook
Calls on Pharma Companies Focused on Vaccines & Therapeutics Against the Monkeypox Virus.
Monkeypox Case Reported in U.S. Emergent Biosolutions Inc (EBS) Makes a Vaccine. - Calls on Emergent Biosolutions
if you missed the COVID-19 run up on PFE or BNTX in 2020, don't miss this Monkey Pox play
EBS options, Monkeypox vaccines being made. Get it while it's still hot
Monkeypox is a thing, I don't want it to be a thing but it is. Lets make money on it.
Monkeypox - What You Need To Know $EBS $BVNRY
MonkeyPox - What You Need To Know $EBS $BVNRY
Managing an Evolving Workforce Creates Challenges and Golden Star Enterprises (GSPT) Offers a Popular Solution. Recently signed contracts and LOI's
Life saving opioid overdose "antidote" Naloxone: demand & profitability EBS (Cynical DD/Shitpost?)
Life saving opioid overdose "antidote" Naloxone: demand & profitability EBS/HKMPY (Cynical DD/Shitpost?)
Life saving opioid overdose "antidote" Naloxone: demand & profitability EBS/EKMPY (Cynical DD/Shitpost?)
Incredible lifesaving opioid overdose/poisoning antidote Naloxone EBS/HKMPY DD (Serious Shit)
$EBS: From $127.20 on February to $32.63 today!
Emergent Biosolutions (EBS), producer of Covid-19 immune globin therapy which began study for 800 patients last week. Current price $64, price target $92.
Emergent Biosolutions (EBS), producer of Covid-19 immune globin therapy which began study for 800 patients last week. Current price $64, price target $92.
Straight from the horses mouth, a look at fines levied against Citadel and their correlation to what’s happening now. And when is the mentality “slap on the wrist” going to become 10-25yr sentence.
EVIL PEOPLE ARE TRYING TO KILL EMERGENT BIOSOLUTIONS AND THAT WILL KILL PEOPLE
[$NOK]🚀🌕 Why Nokia is massivly underated! 🚀🌕$10+
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
$EBS - Take care of your planet, those who protect and invest have! 🚀🌍 Greater growth than the population !!! 1000% Precious 🌍💎
My $23k bet on a big EBS bounce after JNJ vaccine issues are ironed out
EBS down 13%, what do you guys will happen to this stock?
Mentions
EBS has been steadily creeping up since we forgot about it. Rebought to see if we'll return to that $3-4 range.
I would've said RUM but that already moved EBS is dipping so give that one time and it's a banger
In so far as pharma stocks $EBS was the play Will likely set up again for another move after this dip settles Decent short interest, great deals, and I'm demand products The bearish idea of having an interim CEO disappeared and BAM up 100% in day then climbed up even more No flashy hype just a good stock
EBS earnings must be good because stock goes down.
EBS is literally up like 8% since I posted in here today and over 100% since I first posted. Earnings in 2 days
Markets are down and EBS is ripping, it has been for the last few weeks
Great list. Thanks for this. What i dobt understand why here is it different from the short data. When i see on fintel there are only 20 percent for example for EBS stock.
$EBS maker of Narcan. earnings March 6th. Possible squeeze.
$EBS Over the counter narcan. Police, schools, first responders, ect.
$EBS new CEO just announced with a history of turning around company's in their current situation. Combined with Narcan being put everywhere and in the news daily 🚀
Not sure if I would hold for 30 years but I stumbled across EBS; price doubled this week. They announced a new CEO but I’m sure there are other factors supporting the growth…any thoughts?
$EBS PAPA IS THE MAN! 🚀 Narcan nasal spray. Police, Teachers, Parents, etc. Don't have to mess with needles to save someone. It's part of first aid kits now.
EBS stock. Papa will rock the boat.
$EBS Quarterly earnings anytime. Over the counter Narcan nasal spray. No needles needed. Great for Cops, teachers, parents, ect.
I have puts on EBS I feel you.
Has anyone been following EBS? It’s up about 90% in the past week and 80% of that was one day. Earnings on Monday and it’s up 10% today. I’m wondering what and why. I know they appointed a new CEO but surely that doesn’t give it a 90% increase. It is only $3 so probably why The company seems a bit dogshit on my really crappy DD… Probably means it will moon
EBS Yesterday was only the beginning. New Ceo, next week earnibgs with narcan sales. Short havent covered, small float. This stock can run easy more.
Worth holding EBS Post earnings?
Yoooo EBS still rippin dafuq. I usually miss these. Will take profit and short it i think
EBS new CEO announced today!
I’ve been holding EBS OTLY and NBY expecting good things from NBY this week
$EBS over the counter Narcan. Should be a great quarter.
I’m Hoping $SOUN $LXRX $PTPI all stay green & $EBS is soon to follow
Question for everyone. I’ve seen EBS getting posted for a while, but I can’t find a lot of good data on it. Can anyone explain why people are high on it? Looking for something to throw a bit of money at
EBS stock. Narcan producer and the market cap is a joke at the moment.
I've been swing trading this stock since Nov 2nd and have made about 7.5k. I'm now looking into EBS. Black Rock,Charles Schwab,State Street and millennium investments firms have been LOADING up on this stock around 2$ last month
EBS the more manufacturing contracts they secure the higher this goes they are one of the leading companies in narcan production and there is a fentanyl epidemic rn
Where are all my EBS ppl buY low Sell high wins again
Not so glamorous but it was EBS for me. It was doing very well for a while so kept DCAing it. It was not just how much I lost but how much I lost in hours. They were the sole anthrax antidote/ cure. And then another company got approved and their stock just went into free fall. I am not a day trader so completely missed the free fall. Could not believe my eyes at the end of the day.
$EBS stock is being heavily shorted. Q4 earnings later this month will include Narcan sales (FDA approved OTC sales in september) Legislation is currently being put in for requiring Narcan in public/federal buildings, schools, governments/organizations purchasing Narcan and giving it away for free in vending machines all across the country.
Watching EBS trading @ new low might hold over the weekend
EBS extremw cheap and hope for rebound. Good product in pipeline.
EBS is for me the play. Earnings will come in feb. So with narcan i expect good sales.
At the end of yesterday’s session there were interesting moves in EBS and XXII and I will look at them closely today to see if they continue. EBS is quite heavily shorted, so a move upward could trigger an ever bigger one. And XXII has an upcoming extra GM which is usually bad news, but volumes and prices of long term calls looks positive. So, an interesting short term bet.
I think that person could have a point. Given that the opiod crisis that the US has suffered is spreading for example in Europe, and the current instability in the world, I think EBS is a relevant M&A target for one of the bigger players. What would be really interesting would be to find out which fund that has the biggest short position in EBS; I have looked around but without success. If there is a sharp reversal up, they will suffer badly, and even more so when they try to cover their positions…
EBS narcan for all of us to be safe.
My current long positions, with profit takers ~ 10 ATRs from entry and tight stops, are: - $EBS - $HLTH - $XXII - $AHCO - $DNMR - $VWE Fairly low volume, and high short ratio, on some of them, so, if volume on buying side take off, it will trigger more buying. And, if price go against my direction, risk is limited.
Hmm seems like EBS could be due for a bounce here. Fingers crossed the short covering gives it some momentum - lord knows we could all use a win these days!
No way… but Calls on Narcan! $EBS to the mooooon!
The average trading range of EBS is ~ 0.24, and I think a lot of stops are triggered on that. So. i expect the stock to begin moving strong when we pass ~ 2.25 since a lot of short sellers will then start to buy stock. Which will, given the low volume, drive price higher and trigger more exits through buys… So, it’s an exciting position.
For the answer listen (and learn) on Thursday to their presentation... Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 January 9, 2024 (Globe Newswire) GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PT. The audio link for Emergent's session may be accessed on company website, and will be live for up to 30 days.
Thursday is MAKE or BREAK day..... Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 January 9, 2024 GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PT. The audio link for Emergent's session may be accessed on website, and will be live for up to 30 days.
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 GLOBENEWSWIRE 7:30 AM ET 01/09/2024 GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (EBS) , a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PT. The audio link for Emergent's session may be accessed here, and will be live for up to 30 days. The company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website. About Emergent BioSolutions (EBS) At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X (formerly Twitter), and Instagram.
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 GLOBENEWSWIRE 7:30 AM ET 01/09/2024 GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (EBS) , a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PT. The audio link for Emergent's session may be accessed here, and will be live for up to 30 days. The company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website. About Emergent BioSolutions (EBS) At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X (formerly Twitter), and Instagram.
#### Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 GLOBENEWSWIRE 7:30 AM ET 01/09/2024 GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (EBS) , a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PT. The audio link for Emergent's session may be accessed here, and will be live for up to 30 days. The company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website. **About** **Emergent BioSolutions** **(EBS)** At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X (formerly Twitter), and Instagram.
I was doing some research on EBS and sorry for your loss.
EBS is very cheap. The products are good. They produce narcan. So in US are big problems with fentanyl. So i expect huge spike when earnings come.
Small caps are making a comeback...I like Frgt, GRTS, PBLA and EBS.
$EBS long on this one. Makers of Narcan opioid reversal spray. Stock has been bouncing around the 2-2.50 range for 2 months now after a steady decline from pandemic highs in the 100's. Company has been around since early 2000's looks like they are restructuring to focus on Narcan production. Lots of funding from Fed/State/Local government to purchase Narcan. Google it and check out all the news articles.
$EBS. Its a pos but is trading at a cheap valuation
$EBS narcan nasal spray. Police, firemen, teachers, ect.
homie, my soul is hurting with EBS right now
I cannot understand EBS! Look at the share price under $3 with a book value of $15? Even if you took the debt out with their successful operating companies we are talking about a $10 stock at MINIMUM. Am I crazy or am I onto something??? The low EPS recently was from a WRITE DOWN...operating loss around $1/share but has a history and contracts to PRINT IT?!
Keep buying more cgc, EBS, and PayPal easy value stocks prime for the mother load
Buy way more EBS they make narcan and a vaccine for anthrax and it hit A low today def undervalued with huge gains possible.
EBS. Governance is awful, company mismanaged for years with huge avoidable mistakes, and possible stock dilution in the near future. Here’s the hot take: sometime in the next 18 months… it RUNS. The opioid epidemic is just something most investors know exists in theory, but don’t deal with day to day. Over the counter Narcan? This is huge. HUGE. Give it time. Some quarter soon massive sales numbers will come in, and I think very suddenly everyone will try to pile in.
Got some FCEL and EBS calls and if they could go up that'd be greeeeat.
You think EBS is gonna go up more tomorrow?
$EBS Emergent Biosolutions Quick DD “A Turnaround Story” Short Interest Is high Emergent Biosolutions current market cap is at 369 million. According to last quarter they had 430 million in cash more than todays market cap. In February $EBS emergent biosolutions sold a part of there business for 380 million dollar, at the end of close of the deal they will receive 270 million in cash and 110 million in milestones payments. Which in May 2023 the deal has been finalized. In March Emergent Biosolutions received full FDA Approval For “NARCAN” over the counter use. With todays overdoses and drug usage especially at concerts and music festivals this is a MASSIVE WINNER. In July Emergent Biosolutions won the approval for a ANTHRAX VACCINE. And then also in July Emergent Biosolutions won a massive BARDA Contract worth 704 million dollars over ten years. In my opinion Emergent Biosolutions seems like a clear winner in the whole biotech sector with massive rebound. Todays share price is at its lowest possible since its inception and the highest share price for $EBS is 115 per share. There’s a lot of growth here for the short term and long term.
Me to $EBS chart gonna see a major reversal! Earnings gonna be JUICY
#Here’s the TL:dr for blue sheets and why we need to see them for AMC: #Blue Sheet Data Electronic Blue Sheet (EBS) data files, which contain both trading and account holder information, provide regulatory agencies with the ability to analyze a firm’s trading activity. Firms are expected to provide complete, accurate and timely Blue Sheet data in response to regulatory requests. Incomplete, inaccurate and untimely Blue Sheet data compromises regulators’ ability to identify individuals engaging in insider trading schemes and other fraudulent activity. #AMC to the moon 🚀🚀🚀
Maybe something to consider once it gets wrecked a more - like I’m looking at EBS but I want to see it halved from here before considering it.
>1. EBS is a good choice for an uptrending ticker. The company is doing well financially and has a lot of cash on hand compared to what is expected. The float looks good as well, with only 2 million shares traded daily. 2. CARG is a good choice for a downtrending ticker. The company does not have much cash on hand and their financials are not looking great. Additionally, the float looks bad with over 17 million shares traded daily
EBS government contracts about to roll in in this new Narcan OTC product 🤑🤑
EBS 
I’m making gains with EBS. Up 17% They are the pharmaceutical with FDA approval for over the counter narcan nasal spray.
Really bull on EBS since $8.78. Wait till them juicy Biden-Harris drug contract money start coming in. 
Just for fun, checked out [results from last week's Daily Thread](https://i.imgur.com/AG2WVXn.png). Excluded some comments that had tickers, but no comment on them and got no upvotes or replies. I'll keep an eye on $EBS. I like [the chart](https://i.imgur.com/c6DAZCs.png) and [they're producing OTC generic narcan](https://www.fiercepharma.com/manufacturing/emergent-makes-history-first-fda-nod-over-counter-naloxone), but they did [announce layoffs yesterday](https://www.bizjournals.com/washington/news/2023/04/04/emergent-biosolutions-evolent-neximmune-bio-update.html).
Here's what I learned from day trading: I didn't need to trade many stocks everyday. I traded a total of 10 stocks in the entire week (9 profitable, 1 loss). The one loss should've been a win, but I had a stop loss too close. I missed out on a lot of profit I should've made (PALI, VKTX, EBS). The reason I justify the lost potential is the stocks I managed to get out of for small profits (HUBC, PXMD, CDAK, and VORB) . Gains compile and grow, losses do too. I'm new to this trading style, so I will learn to expand profits, but so far my losing strategy is also in its infancy. I've managed to get great luck on all my stocks, but that won't continue. Congrats on the trade!
Hey /u/keithq24 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: EBS. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
EBS is a vertical line right now